Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,246 total articles
James V. Caruso, the Chief Executive Officer of Cellectar Biosciences, Inc. (NASDAQ: CLRB), has executed a series of transactions to increase his direct ownership in the company. On May 7, 2026, Mr. Caruso purchased 8,680 shares of common stock at a price of $2.88 per share, representing a total investment of $24,998. This acquisition brings his to…
Jarrod Longcor, the Chief Operating Officer of Cellectar Biosciences, Inc. (NASDAQ:CLRB), has executed a series of transactions involving both common stock and warrants. On May 7, 2026, Longcor purchased 8,680 shares of common stock at a price of $2.88 per share, representing a total investment of $24,998. This activity comes as the company navigat…
Sarbani Chaudhuri, serving as the Chief Commercial and Medical Affairs Officer for Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), recently completed a transaction involving the sale of company common stock. On May 7, 2026, Ms. Chaudhuri sold 17,650 shares of Rocket Pharmaceuticals common stock at a price per share of $3.838. This transaction resulted…
Alexandra Seros, a 10% owner of Entravision Communications Corp (NASDAQ:EVC), along with the Seros Ulloa Family Trust of 1996, have completed a series of stock sales totaling approximately $10.68 million. These transactions occurred over a five-day window in May 2026, coinciding with a period of intense upward momentum for EVC shares, which have se…
Christopher A. Scott, serving as Senior Vice President at Matson, Inc. (NASDAQ: MATX), has completed a sale of company stock. The transaction involved 3,305 shares of common stock, executed on May 8, 2026. The shares were sold at a price point of $180.14 each, which resulted in total proceeds of $595,362. Following this divestment, Mr. Scott mainta…
Taira Thomas, who serves as the President of Special Projects for Carvana Co. (NASDAQ: CVNA), has completed the sale of Class A Common Stock totaling $447,030. These transactions, which took place on May 8, 2026, were executed through a Rule 10b5-1 trading plan that had been established by Ms. Thomas on August 8, 2025. The sales occurred at price p…
Stefan A. Dyckerhoff, a member of the board of directors at Astera Labs, Inc. (NASDAQ: ALAB), has completed the sale of 12,599 shares of common stock. The transactions, which took place on May 7, 2026, resulted in an aggregate value of $2,500,211. These sales were conducted according to a Rule 10b5-1 trading plan that Mr. Dyckerhoff had established…
Kevin Allen Lansberry, a director at Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH), executed a significant purchase of company common stock on May 7, 2026. The transaction involved the acquisition of 11,400 shares at an average price of $17.28 per share, totaling a $196,992 investment. This move increases Mr. Lansberry's direct holdings in the c…
Sylebra Capital LLC, acting in its capacity as a director for Impinj Inc. (NASDAQ: PI), has completed a notable divestment of the company's common stock. On May 7, 2026, the entity sold 36,171 shares at a price point of $152.73 per share. This transaction resulted in total proceeds of approximately $5,524,396. Following this disposal, Sylebra Capit…
Peter A. Thompson, a director at Sionna Therapeutics, Inc. (NASDAQ: SION), has completed the sale of 292,952 shares of common stock. The transactions, totaling approximately $13.36 million, were conducted in May 2026 and highlight significant insider movement while the company progresses through critical clinical trial phases for cystic fibrosis tr…
Gary Loeb, who serves as the Executive Vice President and Chief Legal and Compliance Officer for Intuitive Surgical Inc (NASDAQ:ISRG), recently completed a sale of company stock. On May 11, 2026, Mr. Loeb sold 400 shares of common stock at a price of $446.95 per share, resulting in total proceeds of $178,780. This transaction was carried out under …
Keith Valentine, a director at Alphatec Holdings, Inc. (NASDAQ: ATEC), has completed a series of transactions totaling $996,192 in common stock. These acquisitions occurred over a four-day period in May 2026, even as the company's share price traded near its 52-week low. The buying activity follows a Q1 earnings report that showed an earnings per s…
Eric Parthemore, a member of the Board of Directors for StoneX Group Inc. (NASDAQ: SNEX), has completed a sale of company common stock. The transaction, which took place on May 11, 2026, involved the disposal of 2,500 shares. This move occurs during a period of significant price appreciation for the firm, as the stock is currently trading near its …
Steven A. Kass, a member of the Board of Directors for StoneX Group Inc. (NASDAQ: SNEX), has completed a sale of company common stock. The transaction, which took place on May 11, 2026, involved the disposal of 2,000 shares at an average price point of $123.2594 per share. This liquidation resulted in total proceeds of $246,518. Following this spec…
Investment entities linked to OrbiMed Advisors LLC have executed a series of stock sales totaling approximately $13.36 million in Sion Therapeutics, Inc. (NASDAQ:SION). The transactions, which were carried out under a pre-arranged 10b5-1 trading plan, took place over several days in early May 2026. These divestments occurred while the company's sto…
Dafna Sharir, a member of the board of directors at Ormat Technologies, Inc. (NYSE: ORA), has completed a sale of common stock totaling $108,114. The transaction took place on May 11, 2026, when 883 shares were sold at a price point of $122.44 per share. This movement in equity follows the recent vesting of Restricted Stock Units (RSUs) earlier in …
Paul A. Laviolette, the Chief Executive Officer of Pulse Biosciences, Inc. (NASDAQ:PLSE), has completed a personal acquisition of 15,000 shares of common stock. The transaction, valued at $295,350, occurred on May 11, 2026. This move by leadership comes as the company manages its recent financial reporting and faces shifting market perceptions rega…
Robert W. Duggan, a director and 10 percent shareholder of Pulse Biosciences, Inc. (NASDAQ:PLSE), has significantly increased his stake in the company through a substantial share acquisition. On May 11, 2026, Mr. Duggan purchased 660,233 shares of common stock for a total consideration of $12,999,987. The transaction was executed at a price of $19.…
James Huang, a director and ten percent owner of Atara Biotherapeutics, Inc. (NASDAQ: ATRA), has reported a substantial sale of company shares. Alongside Panacea Innovation Ltd., Huang executed the disposal of 313,446 shares of common stock on May 7, 2026. The total value realized from this transaction amounted to $3,165,020, based on a weighted av…
John Warren Sullivan, serving as Senior Vice President at Matson, Inc. (MATX), has completed a sale of company common stock totaling $600,046. The divestment took place on May 8, 2026, involving 3,331 shares priced at $180.14 per share. This move follows a period of substantial growth for the company's stock, which has risen approximately 91% over …
Bradley D. Tilden, a member of the board of directors for Matson, Inc. (NYSE: MATX), has completed a sale of company common stock. The transaction, which took place on May 8, 2026, involved the disposal of 1,594 shares. This move occurs while the company's stock is trading at levels significantly higher than its position one year ago, despite recen…
James D. Gray, the Chief Financial Officer of Lamb Weston Holdings, Inc. (NASDAQ: LW), has significantly expanded his position in the company through a recent open-market purchase. On May 11, 2026, Gray acquired 10,000 shares of common stock at prices ranging between $40.90 and $40.945 per share, representing a total investment of $409,225. This mo…
Vasanthavada Madhav, the Chief Commercial Officer at Abeona Therapeutics Inc. (NASDAQ: ABEO), has completed a sale of common stock totaling $33,073. The transaction, which took place on May 11, 2026, involved the sale of 5,548 shares. These shares were sold within a price range between $5.90 and $6.00 per share. According to data from InvestingPro,…
Recent SEC filings reveal that Adam Godderz, the former General Counsel and Secretary of Euronet Worldwide, Inc. (NASDAQ: EEFT), has sold his remaining common stock in the company. This transaction occurred after Godderz concluded his official service with the firm in April 2026. The sale comes at a time when Euronet is navigating a complex market …
George W. LeMaitre, the Chairman and CEO of LeMaitre Vascular Inc. (NASDAQ:LMAT), has completed a series of stock transactions totaling approximately $5.03 million. These sales occurred during the first week of May 2026, specifically on May 7 and May 8. The divestment comes at a time when the company has recently reported strong financial performan…
